+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Joint Pain Injections Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • PDF Icon

    Report

  • 117 Pages
  • August 2022
  • Region: Global
  • Acute Market Reports
  • ID: 5724457
Description Jump to:

Industry Outlook

The joint pain injections market is set to exhibiting outstanding growth at a compound annual growth rate (CAGR) of 9.7% during the forecast period from 2022 to 2030. As per the latest research citing brought forward by Global Burden of Disease Study the burden associated with musculoskeletal disorders is approximately 6.8% of DALYs worldwide.

Excellent lubrication and shock absorbing properties similar to synovial fluid has led to the increasing demand for hyaluronic acid injections for joint pains

Hyaluronic acid injection is reigning the injections segment for joint pain injections market. The human joints are similar to gears subjected to constant wear and tear, hyaluronic acid possess excellent lubrication and shock absorbing properties similar to synovial fluid thereby reducing joint stiffness and tenderness. Corticosteroid injections are used as an adjuvant medication in joint pain owing to its anti-inflammatory properties and ability to provide short term relief in joint sprains experienced by athletes and industrial workers.

Significant rise in tenosynovitis and prolonged physical activity drive the knee & ankle joint market growth

Currently knee & ankle joints are dominating the joint segment for joint pain injections market. The major factors associated with its market growth are significant rise in tenosynovitis and prolonged physical activity. Increasing competition among athletes and rampant growth of production and manufacturing segment further bolster the knee & ankle joints market growth. Shoulder & elbow joints are anticipated to register impressive growth in the near future owing to increasing utilization of electronic gadgets such as laptops, personal computer and mobile phones among general population. Rising prevalence of rotator cuff injury further consolidate the shoulder & elbow joints market growth.

Rising prevalence of obesity and high acceptance of viscosupplementation drive the market growth in North America

North America with a share of 34% is leading the regional segment for joint pain injections market. The chief attributes responsible for its dominance are rising prevalence of obesity and high acceptance of viscosupplementation. Domicile of key players such as Sanofi S.A., Allergan, Plc., Pfizer, Inc. etc. provide necessary impetus to the joint pain injections market growth in North America region. Europe is in the second position with a share of 28% owing to the rising prevalence of osteoarthritis in geriatric population. Affordable reimbursement scenario associated with joint pain injections propel the market growth in European region. Asia Pacific holds 20% market share and will grow at a faster pace during the forecast period on account of significant rise in musculoskeletal disorders and increasing cases of accidents and physical trauma.

Pharmaceutical companies pioneering in the joint pain injections market are Allergan, Plc., Anika Therapeutics, Inc., Bioventus LLC., Chugai Pharmaceutical Co., Ltd., Flexion Therapeutics, Inc., Ferring B.V., Pfizer, Inc., Sanofi S.A., SEIKAGAKU Corporation and Zimmer Biomet Holdings, Inc.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Joint Pain Injections market are as follows:
  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Joint Pain Injections market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Injection

  • Hyaluronic Acid Injections
  • Corticosteroid Injections
  • Others

Joint

  • Hip Joint
  • Knee & Ankle
  • Shoulder & Elbow
  • Facet Joints of the Spine
  • Others

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Joint Pain Injections market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2030.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Joint Pain Injections market?
  • Which is the largest regional market for Joint Pain Injections market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Joint Pain Injections market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Joint Pain Injections market worldwide?


This product will be delivered within 2 business days.

Table of Contents

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Joint Pain Injections Market
2.2. Global Joint Pain Injections Market, By Injection, 2021 (US$ Million)
2.3. Global Joint Pain Injections Market, By Joint, 2021 (US$ Million)
2.4. Global Joint Pain Injections Market, By Geography, 2021 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2021

3. Joint Pain Injections Market: Competitive Analysis
3.1. Market Positioning of Key Joint Pain Injections Market Vendors
3.2. Strategies Adopted by Joint Pain Injections Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2021 Versus 2030

4. Joint Pain Injections Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Joint Pain Injections Market Value, 2020 - 2030, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis

5. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2021 Versus 2030
5.3. Market Segmentation
5.3.1. Hyaluronic Acid Injections
5.3.2. Corticosteroid Injections
5.3.3. Others

6. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2021 Versus 2030
6.3. Market Segmentation
6.3.1. Hip Joint
6.3.2. Knee & Ankle
6.3.3. Shoulder & Elbow
6.3.4. Facet Joints of the Spine
6.3.5. Others

7. North America Joint Pain Injections Market, 2020-2030, USD (Million)
7.1. Market Overview
7.2. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
7.3. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)
7.4.Joint Pain Injections Market: By Region, 2020-2030, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
7.4.1.1.1. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
7.4.1.2.1. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
7.4.1.3.1. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)

8. UK and European Union Joint Pain Injections Market, 2020-2030, USD (Million)
8.1. Market Overview
8.2. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
8.3. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)
8.4.Joint Pain Injections Market: By Region, 2020-2030, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
8.4.1.1.1. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
8.4.1.2.1. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
8.4.1.3.1. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
8.4.1.4.1. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)
8.4.1.5. France
8.4.1.5.1. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
8.4.1.5.1. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
8.4.1.6.1. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)

9. Asia Pacific Joint Pain Injections Market, 2020-2030, USD (Million)
9.1. Market Overview
9.2. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
9.3. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)
9.4.Joint Pain Injections Market: By Region, 2020-2030, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
9.4.1.1.1. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
9.4.1.2.1. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)
9.4.1.3. India
9.4.1.3.1. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
9.4.1.3.1. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
9.4.1.4.1. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
9.4.1.5.1. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
9.4.1.6.1. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)

10. Latin America Joint Pain Injections Market, 2020-2030, USD (Million)
10.1. Market Overview
10.2. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
10.3. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)
10.4.Joint Pain Injections Market: By Region, 2020-2030, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
10.4.1.1.1. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
10.4.1.2.1. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
10.4.1.3.1. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)

11. Middle East and Africa Joint Pain Injections Market, 2020-2030, USD (Million)
11.1. Market Overview
11.2. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
11.3. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)
11.4.Joint Pain Injections Market: By Region, 2020-2030, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
11.4.1.1.1. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
11.4.1.2.1. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
11.4.1.3.1. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)

12. Company Profile
12.1. Allergan, Plc.
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Anika Therapeutics, Inc.
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Bioventus LLC
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Chugai Pharmaceutical Co., Ltd.
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Flexion Therapeutics, Inc.
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Ferring B.V.
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Pfizer, Inc.
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Sanofi S.A.
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. SEIKAGAKU Corporation
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Zimmer Biomet Holdings, Inc.
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives

List of Figures
Figure 1 Global Joint Pain Injections Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Joint Pain Injections Market: Quality Assurance
Figure 5 Global Joint Pain Injections Market, By Injection, 2021
Figure 6 Global Joint Pain Injections Market, By Joint, 2021
Figure 7 Global Joint Pain Injections Market, By Geography, 2021
Figure 8 Market Geographical Opportunity Matrix - Global Joint Pain Injections Market, 2021
Figure 9 Market Positioning of Key Joint Pain Injections Market Players, 2021
Figure 10 Global Joint Pain Injections Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
Figure 11 Global Joint Pain Injections Market, By Injection, 2021 Vs 2030, %
Figure 12 Global Joint Pain Injections Market, By Joint, 2021 Vs 2030, %
Figure 13 U.S. Joint Pain Injections Market (US$ Million), 2020 - 2030
Figure 14 Canada Joint Pain Injections Market (US$ Million), 2020 - 2030
Figure 15 Rest of North America Joint Pain Injections Market (US$ Million), 2020 - 2030
Figure 16 UK Joint Pain Injections Market (US$ Million), 2020 - 2030
Figure 17 Germany Joint Pain Injections Market (US$ Million), 2020 - 2030
Figure 18 Spain Joint Pain Injections Market (US$ Million), 2020 - 2030
Figure 19 Italy Joint Pain Injections Market (US$ Million), 2020 - 2030
Figure 20 France Joint Pain Injections Market (US$ Million), 2020 - 2030
Figure 21 Rest of Europe Joint Pain Injections Market (US$ Million), 2020 - 2030
Figure 22 China Joint Pain Injections Market (US$ Million), 2020 - 2030
Figure 23 Japan Joint Pain Injections Market (US$ Million), 2020 - 2030
Figure 24 India Joint Pain Injections Market (US$ Million), 2020 - 2030
Figure 25 Australia Joint Pain Injections Market (US$ Million), 2020 - 2030
Figure 26 South Korea Joint Pain Injections Market (US$ Million), 2020 - 2030
Figure 27 Rest of Asia Joint Pain Injections Market (US$ Million), 2020 - 2030
Figure 28 Brazil Joint Pain Injections Market (US$ Million), 2020 - 2030
Figure 29 Mexico Joint Pain Injections Market (US$ Million), 2020 - 2030
Figure 30 Rest of Latin America Joint Pain Injections Market (US$ Million), 2020 - 2030
Figure 31 GCC Joint Pain Injections Market (US$ Million), 2020 - 2030
Figure 32 Africa Joint Pain Injections Market (US$ Million), 2020 - 2030
Figure 33 Rest of Middle East and Africa Joint Pain Injections Market (US$ Million), 2020 - 2030

List of Tables
Table 1 Global Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
Table 2 Global Joint Pain Injections Market By Joint, 2020-2030, USD (Million)
Table 3 North America Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
Table 4 North America Joint Pain Injections Market By Joint, 2020-2030, USD (Million)
Table 5 U.S. Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
Table 6 U.S. Joint Pain Injections Market By Joint, 2020-2030, USD (Million)
Table 7 Canada Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
Table 8 Canada Joint Pain Injections Market By Joint, 2020-2030, USD (Million)
Table 9 Rest of North America Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
Table 10 Rest of North America Joint Pain Injections Market By Joint, 2020-2030, USD (Million)
Table 11 UK and European Union Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
Table 12 UK and European Union Joint Pain Injections Market By Joint, 2020-2030, USD (Million)
Table 13 UK Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
Table 14 UK Joint Pain Injections Market By Joint, 2020-2030, USD (Million)
Table 15 Germany Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
Table 16 Germany Joint Pain Injections Market By Joint, 2020-2030, USD (Million)
Table 17 Spain Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
Table 18 Spain Joint Pain Injections Market By Joint, 2020-2030, USD (Million)
Table 19 Italy Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
Table 20 Italy Joint Pain Injections Market By Joint, 2020-2030, USD (Million)
Table 21 France Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
Table 22 France Joint Pain Injections Market By Joint, 2020-2030, USD (Million)
Table 23 Rest of Europe Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
Table 24 Rest of Europe Joint Pain Injections Market By Joint, 2020-2030, USD (Million)
Table 25 Asia Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
Table 26 Asia Joint Pain Injections Market By Joint, 2020-2030, USD (Million)
Table 27 China Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
Table 28 China Joint Pain Injections Market By Joint, 2020-2030, USD (Million)
Table 29 Japan Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
Table 30 Japan Joint Pain Injections Market By Joint, 2020-2030, USD (Million)
Table 31 India Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
Table 32 India Joint Pain Injections Market By Joint, 2020-2030, USD (Million)
Table 33 Australia Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
Table 34 Australia Joint Pain Injections Market By Joint, 2020-2030, USD (Million)
Table 35 South Korea Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
Table 36 South Korea Joint Pain Injections Market By Joint, 2020-2030, USD (Million)
Table 37 Latin America Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
Table 38 Latin America Joint Pain Injections Market By Joint, 2020-2030, USD (Million)
Table 39 Brazil Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
Table 40 Brazil Joint Pain Injections Market By Joint, 2020-2030, USD (Million)
Table 41 Mexico Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
Table 42 Mexico Joint Pain Injections Market By Joint, 2020-2030, USD (Million)
Table 43 Rest of Latin America Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
Table 44 Rest of Latin America Joint Pain Injections Market By Joint, 2020-2030, USD (Million)
Table 45 Middle East and Africa Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
Table 46 Middle East and Africa Joint Pain Injections Market By Joint, 2020-2030, USD (Million)
Table 47 GCC Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
Table 48 GCC Joint Pain Injections Market By Joint, 2020-2030, USD (Million)
Table 49 Africa Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
Table 50 Africa Joint Pain Injections Market By Joint, 2020-2030, USD (Million)
Table 51 Rest of Middle East and Africa Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
Table 52 Rest of Middle East and Africa Joint Pain Injections Market By Joint, 2020-2030, USD (Million)

Companies Mentioned

  • Allergan Plc.
  • Anika Therapeutics Inc.
  • Bioventus LLC.
  • Chugai Pharmaceutical Co. Ltd.
  • Flexion Therapeutics Inc.
  • Ferring B.V.
  • Pfizer Inc.
  • Sanofi S.A.
  • SEIKAGAKU Corporation
  • Zimmer Biomet Holdings Inc.

Related Topics

Related Reports

Joint Pain Injections Market by Injection Type, Joint Type, Distribution Channel - Global Forecast 2025-2030 - Product Image

Joint Pain Injections Market by Injection Type, Joint Type, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Sacroiliac Joint Fusion Injections and RF Ablation Market Size, Share & Trends Analysis Report by Indication (Degenerative Sacroiliitis, Sacral Disruption), Type (Diagnosis), End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Sacroiliac Joint Fusion Injections and RF Ablation Market Size, Share & Trends Analysis Report by Indication (Degenerative Sacroiliitis, Sacral Disruption), Type (Diagnosis), End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 150 Pages
  • Global
From
Joint Pain Injections Global Market Report 2024 - Product Image

Joint Pain Injections Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Technology Landscape, Trends and Opportunities in the Global Needle Free Injection System Market - Product Image

Technology Landscape, Trends and Opportunities in the Global Needle Free Injection System Market

  • Report
  • Global
From
Steroid Injections Market by Product Type, Administration Route, Distribution Channel, Application - Global Forecast 2025-2030 - Product Image

Steroid Injections Market by Product Type, Administration Route, Distribution Channel, Application - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.